Dr. Bhaskar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2017 - 2019
- Ohio State University College of MedicineClass of 2016
Certifications & Licensure
- TN State Medical License 2023 - 2025
- MO State Medical License 2016 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 6 citationsEfficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy.Madiha Iqbal, Deepa Jagadeesh, Julio Chavez, Arushi Khurana, Allison Rosenthal
Bone Marrow Transplantation. 2024-02-01 - 12 citationsChimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.Olalekan O Oluwole, Bhagirathbhai Dholaria, Tristan E Knight, Tania Jain, Frederick L Locke
Transplantation and Cellular Therapy. 2024-02-01 - The Evolving Role of Bridging Therapy during CAR-T Therapy.Shakthi T Bhaskar, Bhagirathbhai Dholaria, Bipin N Savani, Olalekan Oluwole
Clinical Hematology International. 2024-01-01
Journal Articles
- Current and future immunotherapeutic approaches to multiple myeloma therapyBhaskar, S., Benson, DM, International Journal of Hematologic Oncology, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: